Skip to main content
Explore URMC
menu

Monica Javidnia, Ph.D.

Contact Information

Biography

Research

My primary research projects are
1. Relating symptomatic treatments to Parkinson’s disease patient outcomes and self-reported symptom burden
2. Using digital tools (e.g., smartphone applications, sensors) to measure drug pharmacodynamics, disease progression, and clinically-meaningful outcomes/events (e.g., time to treatment, falls, cognitive impairment)

Credentials

Education

2011
BS | University of Texas at Dallas
Neuroscience

2012
MS | University of Texas at Dallas
Applied Cognition and Neuroscience

2017
PhD | Georgetown University
Pharmacology

Post-doctoral Training & Residency

2017 - 2020
University of Rochester Medical Center

Awards

2019 - 2020
TEDMED Research Scholar

Publications

Journal Articles

7/7/2021
Javidnia M, Arbatti L, Hosamath A, Eberly SW, Oakes D, Shoulson I. "Predictive Value of Verbatim Parkinson's Disease Patient-Reported Symptoms of Postural Instability and Falling." Journal of Parkinson's disease.. 2021 Jul 7; Epub 2021 Jul 07.

7/2021
Gosztyla ML, Kwong L, Murray NA, Williams CE, Behnke N, Curry P, Corbett KD, DSouza KN, Gala de Pablo J, Gicobi J, Javidnia M, Lotay N, Prescott SM, Quinn JP, Rivera ZMG, Smith MA, Tang KTY, Venkat A, Yamoah MA. "Responses to 10 common criticisms of anti-racism action in STEMM." PLoS computational biology.. 2021 Jul; 17(7):e1009141. Epub 2021 Jul 15.

4/24/2021
Ahamadi M, Mehrotra N, Hanan N, Yee KL, Gheyas F, Anton J, Bani M, Boroojerdi B, Smit H, Weidemann J, Macha S, Thuillier V, Chen C, Yang M, Williams-Gray CH, Stebbins GT, Pagano G, Hang Y, Marek K, Venuto CS, Javidnia M, Dexter D, Pedata A, Stafford B, Akalu M, Stephenson D, Romero K, Sinha V, . "A disease progression model to quantify the non-motor symptoms of Parkinson's disease in participants with leucine-rich repeat kinase 2 mutation." Clinical pharmacology and therapeutics.. 2021 Apr 24; Epub 2021 Apr 24.

VIEW ALL PUBLICATIONS